References
1. Dubois, C., et al., Multidisciplinary work in oncology: Population-based analysis for seven invasive tumours. Eur J Cancer Care (Engl), 2018. 27 (2): p. e12822.
2. Serruys, P.W., et al., Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med, 2009. 360 (10): p. 961-72.
3. Girasis, C., et al., SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial. Eur Heart J, 2011. 32 (24): p. 3115-27.
4. Kappetein, A.P., et al., Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase. Eur J Cardiothorac Surg, 2006. 29 (4): p. 486-91.
5. Head, S.J., et al., The rationale for Heart Team decision-making for patients with stable, complex coronary artery disease. Eur Heart J, 2013. 34 (32): p. 2510-8.
6. Neumann, F.J., et al., [2018 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS)]. G Ital Cardiol (Rome), 2019. 20 (7-8 Suppl 1): p. 1S-61S.
7. Shahian, D.M., et al., The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1–coronary artery bypass grafting surgery. Ann Thorac Surg, 2009. 88 (1 Suppl): p. S2-22.
8. Rui, A., et al., Are the guidelines for coronary artery revascularization, according to the syntax score, being correctly applied, by a heart team? 2015, Journal of Cardiothoracic Surgery. p. A 183.
9. Domingues, C.T., et al., Heart Team decision making and long-term outcomes for 1000 consecutive cases of coronary artery disease. Interact Cardiovasc Thorac Surg, 2019. 28 (2): p. 206-213.
10. Patel, M.R., et al., ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society of Thoracic Surgeons. J Am Coll Cardiol, 2017. 69 (5): p. 570-591.
11. Mohr, F.W., et al., Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet, 2013. 381 (9867): p. 629-38.
12. Boudriot, E., et al., Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis. J Am Coll Cardiol, 2011. 57 (5): p. 538-45.
13. Park, S.J., et al., Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med, 2011.364 (18): p. 1718-27.
14. Park, S.J., et al., Trial of everolimus-eluting stents or bypass surgery for coronary disease. N Engl J Med, 2015.372 (13): p. 1204-12.
15. Mäkikallio, T., et al., Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. Lancet, 2016. 388 (10061): p. 2743-2752.
16. Head, S.J., et al., Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data.Lancet, 2018. 391 (10124): p. 939-948.
17. Holmes, D.R., et al., The heart team of cardiovascular care.J Am Coll Cardiol, 2013. 61 (9): p. 903-7.
18. Farkouh, M.E., et al., Strategies for multivessel revascularization in patients with diabetes. N Engl J Med, 2012.367 (25): p. 2375-84.
19. Abdulrahman, M., et al., Impact of Hierarchy on Multidisciplinary Heart-Team Recommendations in Patients with Isolated Multivessel Coronary Artery Disease. J Clin Med, 2019. 8 (9).
20. Bonzel, T., V. Schächinger, and H. Dörge, Description of a Heart Team approach to coronary revascularization and its beneficial long-term effect on clinical events after PCI. Clin Res Cardiol, 2016.105 (5): p. 388-400.
21. Sanchez, C.E., et al., Revascularization heart team recommendations as an adjunct to appropriate use criteria for coronary revascularization in patients with complex coronary artery disease.Catheter Cardiovasc Interv, 2016. 88 (4): p. E103-E112.
22. Damman, P., et al., 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: comments from the Dutch ACS working group. Neth Heart J, 2017. 25 (3): p. 181-185.